mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |